BrainStorm Cell Therapeutics Inc., of New York, said it raised about $3.6 million from the sale of 12.8 million shares at 28 cents per share in a private placement financing. The company also said it issued warrants to the investors, with exercise prices of 28 cents and 50 cents per share, with expiration dates of one year and two years, respectively.